Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by coalbeton Mar 28, 2017 3:18pm
191 Views
Post# 26042174

A no brainer!

A no brainer!Anti Cancer Platform Technology Patented anti-cancer drugs known as Photo Dynamic Compounds (PDCs) localize to the DNA of cancer cells and when light activated destroy the DNA resulting in natural cell death (apoptosis) Highlights 100% cancer cell kill at very low concentrations (< 0.8µM) No toxicity at high concentrations (> 100µM) leading to very high safety profile More effective at killing cancer cells than FDA approved drugs (668,000 x ALA, 198 x PHOTOFRIN) No side effects were observed from treatment (quick evacuation of PDC from healthy cells and high light fluence required for activation provides extremely high safety profile) Ultra low toxicity as PDC never enters blood stream (bladder cancer) Water soluble & readily penetrates cellular membrane (DNA localizing) Activated by laser light providing excellent specificity and selectivity Lethal to cancer and bacteria Able to treat solid core hypoxic tumours, such as: breast, prostate and lung Research performed at world renowned Princess Margaret Cancer Centre Activated at long wavelengths (allows deeper tumour destruction) Issued USA Patents: 6,962,910, 7,612,057, 8,148,360, 8,445,475 Pending USA Patent Applications: 61/801,674, 13/863,089, PCT/US13/36595
Bullboard Posts